Shares of Uber Technologies (NYSE: UBER) plunged more than 10% immediately after the company reported second quarter 2019 results. The ridesharing firm reported a loss of $4.72 per share on revenue of $3.17 billion. The market had expected Uber to report a loss of $3.20 per share on revenue of $3.39 billion for the recently ended quarter. Rival Lyft (NASDAQ: LYFT) reported better-than-expected Q2 results yesterday and lifted fiscal 2019 outlook.
Gross bookings surged 31% to $15.76 billion in the second quarter, while Core Platform gross bookings soared 30% to $15.57 billion. Monthly active platform consumers (MAPCs) increased 30% to 99 million, while trips in the quarter jumped 36% to 1.68 billion.
Total costs and expenses in 2Q increased to $8.65 billion from $3.51 billion in the prior-year quarter. As expected, the excess driver incentives increased year-over-year in the second quarter. The company had spent $263 million for excess driver incentives versus $163 million in the second quarter of 2018.
“Our platform strategy continues to deliver strong results, with Trips up 35% and Gross Bookings up 37% in constant currency, compared to the second quarter of last year,” said CEO Dara Khosrowshahi.
“In July, the Uber platform reached over 100 million Monthly Active Platform Consumers for the first time, as we become a more and more integral part of everyday life in cities around the world,” he added.
Since becoming a public company in May, Uber had closed above its IPO price of $45 in just two trading days. Shares of Uber ended up 8.24% at $42.97 today as the company got a lift from the stronger-than-expected Q2 results announced by its rival Lyft yesterday evening.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments
Comments are closed.